Patents by Inventor Teresa Phillips
Teresa Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240398917Abstract: Provided are methods for preventing initiation and/or progression of gastrin-associated tumors and/or cancers in subjects. In some embodiments, the methods relate to administering compositions that gastrin immunogens to subjects. Also provided are methods for inhibiting development of gastrin-associated precancerous lesions, methods for preventing formation of fibrosis associated with a tumor and/or a cancer, uses of compositions that include a gastrin immunogen to prevent initiation and/or development of a gastrin-associated tumor or cancer and/or for preparing medicaments therefor, and compositions for use in preventing initiation and/or development of gastrin-associated tumors and/or cancers and/or precancerous lesions thereof.Type: ApplicationFiled: January 13, 2022Publication date: December 5, 2024Applicant: Cancer Advances Inc.Inventors: Lynda Sutton, Jill P. Smith, Allen Cato, Teresa Phillips
-
Patent number: 12150978Abstract: Provided are methods for preventing initiation and/or progression of gastrin-associated tumors and/or cancers in subjects. In some embodiments, the methods relate to administering compositions that gastrin immunogens to subjects. Also provided are methods for inhibiting development of gastrin-associated precancerous lesions, methods for preventing formation of fibrosis associated with a tumor and/or a cancer, uses of compositions that include a gastrin immunogen to prevent initiation and/or development of a gastrin-associated tumor or cancer and/or for preparing medicaments therefor, and compositions for use in preventing initiation and/or development of gastrin-associated tumors and/or cancers and/or precancerous lesions thereof.Type: GrantFiled: January 13, 2021Date of Patent: November 26, 2024Assignee: Cancer Advances Inc.Inventors: Lynda Sutton, Jill P. Smith, Allen Cato, Teresa Phillips
-
Patent number: 12024638Abstract: The present invention is a composition comprising a blend of a PVA based latex and an EA/MMA based polyacrylic latex. The composition of the present invention is useful in a paint formulation for providing a coating with superior scrub resistance over a formulation comprising a blend of a PVA based latex and a BA/MMA based polyacrylic latex.Type: GrantFiled: August 4, 2020Date of Patent: July 2, 2024Assignees: Rohm and Haas Company, Dow Global Technologies LLCInventors: Azize Ala, Gary W. Dombrowski, Catheryn L. Jackson, Partha S. Majumdar, Teresa A. Phillips, Sharon M. Vuong, Steven G. Arturo
-
Publication number: 20230374332Abstract: The present invention relates to a method for preparing a multiplicity of containers of paint from a plurality of vessels separately containing an aqueous solution of a rheology modifier, an aqueous dispersion of a colorant, an aqueous dispersion of polymer particles, and an aqueous dispersion of organic polymeric microspheres. In another embodiment, the present invention relates to a method of dispensing a colorant or an opacifying agent or an inorganic extender into separate containers partially filled with a waterborne pre-paint mixture of rheology modifier, polymer particles, and organic polymeric microspheres. The process of the present invention provides a simple and cost-effective way of preparing a wide variety of a large quantity of contained and finished paints at point-of-sale.Type: ApplicationFiled: June 21, 2021Publication date: November 23, 2023Inventors: James C. Bohling, Ibrahim Eryazici, Philip R. Harsh, Partha S. Majumdar, Mario G. L. Mirabelli, Edwin A. Nungesser, Teresa A. Phillips, Daniel A. Saucy
-
Publication number: 20230357585Abstract: The present invention relates to a composition comprising an aqueous dispersion of a) polymer particles having a z-average particle size in the range of from 80 nm to 500 nm; b) polymeric crosslinked organic microspheres having a D50 particle size in the range of from 1 ?m to 30 ?m; c); a colorant and d) a zinc or zirconium compound. The composition of the present invention is useful for reducing leaching from a coating prepared from a deep base, low sheen paint formulation.Type: ApplicationFiled: October 19, 2021Publication date: November 9, 2023Inventors: James C. Bohling, Sarah D. Hann, Philip R. Harsh, Partha S. Majumdar, Teresa A. Phillips, Thomas W. Suder
-
Publication number: 20230174801Abstract: The present invention relates to a method for preparing a multiplicity of containers of paints or pre-paints from separate vessels containing an aqueous solution of a rheology modifier, optionally an aqueous dispersion of an opacifying pigment, an aqueous dispersion of polymer particles, and an aqueous dispersion of organic polymeric microspheres. The process of the present invention provides a simple and cost-effective way of preparing a wide variety of a large quantity of contained and finished paints at point-of-sale.Type: ApplicationFiled: June 21, 2021Publication date: June 8, 2023Applicants: Rohm and Haas Company, Rohm and Haas CompanyInventors: James C. Bohling, Ibrahim Eryazici, Philip R. Harsh, Partha S. Majumdar, Edwin A. Nungesser, Teresa A. Phillips, Sharon M. Vuong, Xiangyi Zhang
-
Publication number: 20220275238Abstract: The present invention is a composition comprising a blend of a PVA based latex and an EA/MMA based polyacrylic latex. The composition of the present invention is useful in a paint formulation for providing a coating with superior scrub resistance over a formulation comprising a blend of a PVA based latex and a BA/MMA based polyacrylic latex.Type: ApplicationFiled: August 4, 2020Publication date: September 1, 2022Inventors: Azize Ala, Gary Dombrowski, Catheryn L. Jackson, Partha S. Majumdar, Teresa A. Phillips, Sharon M. Vuong, Steven G. Arturo
-
Publication number: 20210275649Abstract: Provided are methods for preventing initiation and/or progression of gastrin-associated tumors and/or cancers in subjects. In some embodiments, the methods relate to administering compositions that gastrin immunogens to subjects. Also provided are methods for inhibiting development of gastrin-associated precancerous lesions, methods for preventing formation of fibrosis associated with a tumor and/or a cancer, uses of compositions that include a gastrin immunogen to prevent initiation and/or development of a gastrin-associated tumor or cancer and/or for preparing medicaments therefor, and compositions for use in preventing initiation and/or development of gastrin-associated tumors and/or cancers and/or precancerous lesions thereof.Type: ApplicationFiled: January 13, 2021Publication date: September 9, 2021Applicant: Cancer Advances Inc.Inventors: Lynda Sutton, Jill P. Smith, Allen Cato, Teresa Phillips
-
Publication number: 20150045386Abstract: The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.Type: ApplicationFiled: August 25, 2014Publication date: February 12, 2015Inventors: Merouane Bencherif, Lisa Benson, Gary Maurice Dull, Nikolai Federov, Gregory J. Gatto, Kristen G. Jordan, Anatoly A. Mazurov, Lan Miao, Julio A. Munoz, Inigo Pfeffier, Sondra Pfeiffer, Teresa Phillips
-
Patent number: 8846715Abstract: The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.Type: GrantFiled: July 22, 2013Date of Patent: September 30, 2014Assignee: Targacept, Inc.Inventors: Merouane Bencherif, Lisa Benson, Gary Maurice Dull, Nikolai Federov, Gregory J. Gatto, Kristen G. Jordan, Anatoly A. Mazurov, Lan Miao, Julio A. Munoz, Inigo Pfeiffer, Sondra Pfeiffer, Teresa Phillips
-
Publication number: 20140024673Abstract: The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.Type: ApplicationFiled: July 22, 2013Publication date: January 23, 2014Applicant: Targacept,Inc.Inventors: Merouane Bencherif, Lisa Benson, Gary Maurice Dull, Nikolai Federov, Gregory J. Gatto, Kristen G. Jordan, Anatoly A. Mazurov, Lan Miao, Julio A. Munoz, Inigo Pfeiffer, Sondra Pfeiffer, Teresa Phillips
-
Patent number: 8541446Abstract: The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.Type: GrantFiled: May 26, 2011Date of Patent: September 24, 2013Assignee: Targacept, Inc.Inventors: Merouane Bencherif, Lisa Benson, Gary Maurice Dull, Nikolai Fedorov, Gregory J. Gatto, Kristen G. Jordan, Anatoly A. Mazurov, Lan Miao, Julio A. Munoz, Inigo Pfeiffer, Sondra Pfeiffer, Teresa Phillips
-
Publication number: 20060247270Abstract: The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The aryl group in the arylalkyl moiety is a 5- or 6-membered ring heteroaromatic, preferably 3-pyridinyl and 5-pyrimidinyl moieties, and the alkyl group is typically a C1-4 alkyl. The substituent at the 3-position of the 1-azabicycloalkane is a carbonyl group-containing moiety, such as an amide, carbamate, urea, thioamide, thiocarbamate, thiourea or similar functionality. The compounds exhibit activity at nicotinic acetylcholine receptors (nAChRs), particularly the ?7 nAChR subtype, and are useful towards modulating neurotransmission and the release of ligands involved in neurotransmission.Type: ApplicationFiled: July 18, 2006Publication date: November 2, 2006Inventors: Anatoly Mazurov, Jozef Klucik, Lan Miao, Angela Seamans, Teresa Phillips, Jeffrey Schmitt, Craig Miller
-
Publication number: 20050282823Abstract: Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia), are treated by administering a compound of Formulas 1 or 2, as described herein. The compounds of Formulas 1 and 2 are also useful for treating pain, and treating drug addiction, nicotine addiction, and/or obesity. The compounds can exist as individual stereoisomers, racemic mixtures, diastereomers and the like.Type: ApplicationFiled: October 15, 2004Publication date: December 22, 2005Applicant: TARGACEPT, INC.Inventors: Scott Breining, Balwinder Bhatti, Gregory Hawkins, Lan Miao, Anatoly Mazurov, Teresa Phillips, Craig Miller
-
Publication number: 20050255040Abstract: The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The aryl group in the arylalkyl moiety is a 5- or 6-membered ring heteroaromatic, preferably 3-pyridinyl and 5-pyrimidinyl moieties, and the alkyl group is typically a C1-4 alkyl. The substituent at the 3-position of the 1 -azabicycloalkane is a carbonyl group-containing moiety, such as an amide, carbamate, urea, thioamide, thiocarbamate, thiourea or similar functionality. The compounds exhibit activity at nicotinic acetylcholine receptors (nAChRs), particularly the ?7 nAChR subtype, and are useful towards modulating neurotransmission and the release of ligands involved in neurotransmission.Type: ApplicationFiled: June 20, 2005Publication date: November 17, 2005Inventors: Anatoly Mazurov, Jozef Klucik, Lan Maio, Angela Seamans, Teresa Phillips, Jeffrey Schmitt, Craig Miller
-
Publication number: 20030158209Abstract: Compounds which function as melanocortin receptor ligands and having utility in the treatment of melanocortin receptor-based disorders.Type: ApplicationFiled: October 9, 2002Publication date: August 21, 2003Applicant: Neurocrine Biosciences Inc.Inventors: Brian P. Dyck, Val Goodfellow, Teresa Phillips, Jessica Parker, Xiaohu Zhang, Chen Chen, Joe Anh Tran, Joseph Pontillo, Fabio C. Tucci